Press release
Nucleic Acid Therapeutics Market reached US$ 5.64 billion in 2024 and is expected to reach US$ 14.42 billion by 2032 - Gilead Sciences, Inc., AstraZeneca, Sarepta Therapeutics, Inc.
Nucleic Acid Therapeutics Market
Nucleic Acid Therapeutics Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/nucleic-acid-therapeutics-market
The Nucleic Acid Therapeutics market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Nucleic acid therapeutics involve the use of DNA or RNA molecules to treat genetic and acquired diseases. These therapies, including antisense oligonucleotides, siRNA, and mRNA, can regulate gene expression or correct genetic mutations. They hold immense promise for addressing rare diseases, cancers, and infectious conditions.
Forecast Growth Projected:
The Global Nucleic Acid Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Nucleic Acid Therapeutics Market:
Ionis Pharmaceuticals, Alnylam Pharmaceuticals, Inc., Gilead Sciences, Inc., AstraZeneca, Sarepta Therapeutics, Inc., Creative Biolabs, GSK plc, Novartis AG, BioNTech SE., and Silence Therapeutics.
Segment Covered in the Nucleic Acid Therapeutics Market:
By category: Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Messenger RNA (mRNA), Self-Amplifying RNA (saRNA).
By application: Cancers, Viral Infections, Genetic Disorders, Others.
By end-user: Hospitals, Academic & Research Institutes.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=nucleic-acid-therapeutics-market
Industry Development:
In October 2024, Leal Therapeutics, Inc. secured $45 million in financing, led by Newpath Partners. New investors, including Chugai Venture Fund and Alexandria Venture Investments, joined existing backers such as OrbiMed, Euclidean Capital, and PhiFund. This funding follows a previously disclosed $39 million financing round.
Transform Your Strategy with Expert Market Analysis: https://www.datamintelligence.com/competitive-intelligence
Regional Break out:
The global Nucleic Acid Therapeutics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Nucleic Acid Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Nucleic Acid Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Speak to Our Senior Analyst and Get Customization in the report as per your requierments: https://datamintelligence.com/customize/nucleic-acid-therapeutics-market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Nucleic Acid Therapeutics market?
➠ Who are the global key manufacturers of the Nucleic Acid Therapeutics Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Nucleic Acid Therapeutics market opportunities and threats faced by the vendors in the global Nucleic Acid Therapeutics Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Nucleic Acid Therapeutics market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nucleic Acid Therapeutics Market reached US$ 5.64 billion in 2024 and is expected to reach US$ 14.42 billion by 2032 - Gilead Sciences, Inc., AstraZeneca, Sarepta Therapeutics, Inc. here
News-ID: 3826477 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Germany Medical Technology market reached US$ 42.2 billion in 2023 and is expect …
The Germany Medical Technology market reached US$ 42.2 billion in 2023 and is expected to reach US$ 62.63 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
Germany's Medical Technology Market encompasses devices, diagnostic equipment, and digital health solutions. Growth is driven by aging populations, chronic disease prevalence, and healthcare innovation. Hospitals, clinics, and research centers are major end-users. Innovations focus on minimally invasive devices, AI…
Biopesticides Market Projected to Reach US$24.16B by 2032, Growing at a CAGR of …
The Biopesticides Market was valued at US$ 7,734.43 million in 2024 and is projected to reach US$ 24,158.10 million by 2032, registering a CAGR of 15.3% during the forecast period 2025-2032.
The market focuses on the development and use of biological pest control solutions derived from natural organisms, including microorganisms, plant extracts, and bioactive compounds. Biopesticides are widely applied in agriculture, horticulture, and forestry to control pests, enhance crop protection, and…
Japan Wearable Devices Market to Hit $12.31 Billion by 2033, Growing at 12.6% CA …
The Japan wearable devices market reached US$4,026.98 million in 2024 and is expected to reach US$12,310.52 million by 2033, growing at a CAGR of 12.6 % during the forecast period 2025-2033, according to DataM intelligence.
Japan's Wearable Devices Market includes smartwatches, fitness trackers, health monitors, and AR/VR devices. Growth is driven by healthcare monitoring, fitness trends, and IoT adoption. Applications span personal wellness, remote patient monitoring, and industrial safety. Companies and…
Germany Probiotic Drinks Market was US$ 1,006.76 million in 2020 and is expected …
The Germany Probiotic Drinks Market was US$ 1,006.76 million in 2020 and is expected to reach US$ 1,738.01 million in 2028 growing at a CAGR of 7.76% during the forecast period (2025-2028).
Germany's Probiotic Drinks Market includes beverages fortified with live microorganisms promoting gut health and immunity. Growth is driven by wellness trends, functional foods demand, and consumer awareness. Products include yogurts, fermented drinks, and kefir. Retail, health food stores, and…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
